Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study.
Alberto PapiBradley E ChippsRichard BeasleyReynold A PanettieriElliot IsraelMark CooperLynn DunsireAllison Jeynes-EllisRobert ReesFrank C AlbersChristy CappellettiPublished in: Therapeutic advances in respiratory disease (2024)
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.